EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Reassessment of Sarcopenia from a Redox Perspective as a Basis for Preventive and Therapeutic Interventions

Alessia Arcaro, Alessio Lepore iD, Giovanni Paolo Cetrangolo iD, Gianluca Paventi iD, Paul Richard Julian Ames iD, Fabrizio Gentile iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167787 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alessia Arcaro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Health Sciences 'V. Tiberio', University of Molise, 86100 Campobasso, Italy. Hauptthemen laut MEDLINE: Sarcopenia, Antioxidants. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 348 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Plan for NRRP Complementary Investments D3 4 Health, National Plan for NRRP Complementary Investments D3 4 Health: Digital-driven diagnostics, prognostics and therapeutics for sustainable health care, Fondazione Anticorpi Antifosfolipidi (APS) Onlus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of a wide variety of antioxidants has been advocated as a means to prevent, delay the progression of, or counteract the adverse consequences of sarcopenia, such as loss of muscle strength, muscle quantity/quality, and physical performance. However, these proposals do not always appear to be supported in the literature by a thorough understanding of the contribution of redox perturbations to the pathogenesis of sarcopenia, nor of the biochemical properties, mechanism of action, pharmacokinetics, and pharmacodynamics of different antioxidants. This review discusses these aspects, aiming to provide a rationale for the selection and use of antioxidants in sarcopenia. After providing a definition of sarcopenia in the context of frailty, we distinguish between oxidative eustress as a physiological response of muscle cells to mild stimulation, such as moderate exercise, mediating their capacity for adaptation and regeneration, and oxidative distress as a pathophysiological response to muscle cell damage and death. The role of oxidative damage to biological macromolecules, both direct and mediated by advanced lipid peroxidation end products and advanced glycation/glycoxidation end products, is examined in detail. Next, we discuss antioxidant defense mechanisms, both enzymatic and non-enzymatic, including redox-sensitive gene regulatory events presided over by nuclear factor erythroid 2-related factor 2, the master regulator of enzymatic antioxidants. The review then discusses criteria for a rational classification of non-enzymatic antioxidants. This is followed by a review of some of the main radical-trapping antioxidants, both phenolic and non-phenolic, whose characteristics are compared.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaAntioxidantsHumansOxidation-ReductionOxidative StressAnimalsMuscle, Skeletal

Stichwörter der Autor:innen

advanced glycation/glycoxidation end products (AGEs)advanced lipid peroxidation end products (ALEs)antioxidantsoxidative stressreactive nitrogen species (RNS)reactive oxygen species (ROS)sarcopenia

Substanzen

Antioxidants

Autor:innen und Institutionen

  • Department of Medicine and Health Sciences 'V. Tiberio', University of Molise, 86100 Campobasso, Italy.
  • Department of Agricultural, Environmental and Food Sciences, University of Molise, 86100 Campobasso, Italy.
  • Immune Response & Vascular Disease Unit, CEDOC, Nova University Lisbon, 1169-056 Lisbon, Portugal.
  • Department of Haematology, Dumfries Royal Infirmary, Cargenbridge, Dumfries DG2 8RX, UK.

ORCID-Profile: Alessio Lepore, Giovanni Paolo Cetrangolo, Gianluca Paventi, Paul Richard Julian Ames, Fabrizio Gentile

Förderung

  • National Plan for NRRP Complementary Investments D3 4 Health
  • National Plan for NRRP Complementary Investments D3 4 Health: Digital-driven diagnostics, prognostics and therapeutics for sustainable health care
  • Fondazione Anticorpi Antifosfolipidi (APS) Onlus

Zitieren

APA

Arcaro, A., Lepore, A., Cetrangolo, G. P., Paventi, G., Ames, P. R. J., & Gentile, F. (2025). A Reassessment of Sarcopenia from a Redox Perspective as a Basis for Preventive and Therapeutic Interventions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167787

Vancouver

Arcaro A, Lepore A, Cetrangolo GP, Paventi G, Ames PRJ, Gentile F. A Reassessment of Sarcopenia from a Redox Perspective as a Basis for Preventive and Therapeutic Interventions. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167787

BibTeX
@article{Arcaro2025,
  author = {Arcaro, Alessia and Lepore, Alessio and Cetrangolo, Giovanni Paolo and Paventi, Gianluca and Ames, Paul Richard Julian and Gentile, Fabrizio},
  title = {A Reassessment of Sarcopenia from a Redox Perspective as a Basis for Preventive and Therapeutic Interventions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167787}
}
Kostenlos starten →